Per Nived
Overview
Explore the profile of Per Nived including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frodlund M, Nived P, Chatzidionysiou K, Sodergren A, Klingberg E, Hansson M, et al.
Microbiol Spectr
. 2024 Mar;
12(4):e0298123.
PMID: 38441463
Importance: Results from this study provide further evidence that additional doses of COVID-19 vaccines are immunogenic and result in satisfactory antibody response in a majority of patients with inflammatory rheumatic...
2.
Frodlund M, Nived P, Chatzidionysiou A, Sodergren A, Klingberg E, Bengtsson A, et al.
Vaccine
. 2023 Apr;
41(20):3247-3257.
PMID: 37076360
Objectives: To elucidate antibody responses after the second and third dose of COVID-19 vaccine in patients with inflammatory rheumatic diseases (IRD) treated with biologic/targeted disease modifying anti-rheumatic drugs (b/ts DMARDs)....
3.
Elmer E, Nived P, Pettersson A, Skattum L, Hellmark T, Kapetanovic M, et al.
J Immunol Res
. 2022 Aug;
2022:7561661.
PMID: 35935581
Patients with rheumatoid arthritis (RA) have an increased risk of infections; therefore, immunization against vaccine-preventable diseases is important. Methotrexate (MTX) impairs the antibody response to pneumococcal conjugate vaccine (PCV) in...
4.
Nived P, Pettersson A, Jonsson G, Bengtsson A, Settergren B, Skattum L, et al.
Sci Rep
. 2021 Apr;
11(1):9199.
PMID: 33911135
Methotrexate (MTX) impairs antibody response after pneumococcal vaccination. We aimed to investigate differences in phenotypes of circulating B and T cells after pneumococcal conjugate vaccine (PCV) in rheumatoid arthritis (RA)...
5.
Nived P, Jonsson G, Settergren B, Einarsson J, Olofsson T, Jorgensen C, et al.
Arthritis Res Ther
. 2020 Jun;
22(1):162.
PMID: 32591025
An amendment to this paper has been published and can be accessed via the original article.
6.
Nived P, Jonsson G, Settergren B, Einarsson J, Olofsson T, Jorgensen C, et al.
Arthritis Res Ther
. 2020 Feb;
22(1):36.
PMID: 32087733
Objective: To explore whether a prime-boost vaccination strategy, i.e., a dose of pneumococcal conjugate vaccine (PCV) and a dose of 23-valent polysaccharide vaccine (PPV23), enhances antibody response compared to single...
7.
Nived P, Saxne T, Geborek P, Mandl T, Skattum L, Kapetanovic M
BMC Rheumatol
. 2019 Mar;
2:12.
PMID: 30886963
Background: Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (RA) and primary Sjögren's syndrome (pSS). However, little is known whether the diseases influence pneumococcal vaccine response. This study aimed...
8.
Nived P, Nagel J, Saxne T, Geborek P, Jonsson G, Skattum L, et al.
Vaccine
. 2017 May;
35(29):3639-3646.
PMID: 28552512
Aim: To study the effect of standard of care therapy on antibody response and functionality following immunization with 13-valent pneumococcal conjugate vaccine (PCV13) in patients with primary systemic vasculitis compared...
9.
Nived P, Jorgensen C, Settergren B
Vaccine
. 2015 Feb;
33(14):1688-94.
PMID: 25707692
Overwhelming post-splenectomy infection (OPSI) is immediately life-threatening and vaccination against encapsulated bacteria, in particular pneumococci, decreases its incidence. First, we investigated the adherence to vaccination guidelines in a retrospective study...
10.
Alsterlund R, Nived P
Lakartidningen
. 2014 Jan;
110(47):2112-4.
PMID: 24437100
No abstract available.